Table 4.
Summary of tissue and EGL biomarker quantification at the time of operation (OR) and 24–48 hours after operation
| Assay | OR | 24–48 h |
|---|---|---|
| CD138 (peritoneum), cells per HPF | 1 (1) | |
| CD138 (pathology), cells per HPF | 3 (1–6) | |
| Hyaluronic acid (plasma), ng/mL | 537.9 (286.7–1032.6) | 423.6 (159.1–733.6) |
| Syndecan-1 (plasma), ng/mL | 35.2 (13.1–46.8) | 51.2 (19.6–85.6) |
CD138 positivity is presented as counts within a high-powered field (400 ×, 0.237 mm2) with IQR.
HPF, high-power field; OR, operating room; SOFA, Sequential Organ Failure Assessment.